Diabetes & Endocrinology Clinical Trials Update: Week 24, 2026

Published June 12, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

A Study of DA-302168S in Participants With Overweight/Obesity

This Phase III trial is testing a new medication, DA-302168S, for people with overweight or obesity. Conducted in China, the study aims to see if the tablets can safely help reduce body weight in a large group of participants. If the results are positive, this could become a new treatment choice for weight management.

A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity

This completed Phase 3 study compared IBI362 to Semaglutide in adults with early type 2 diabetes and obesity in China. Both drugs are given as once-weekly injections. The results will help determine if IBI362 is a safe and effective alternative that can manage blood sugar and weight simultaneously, which is important for improving overall health in people with these conditions.

Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

This Phase 4 study is looking at how Metformin, combined with a low-calorie diet, affects weight and quality of life in adults with diabetes and obesity. Conducted at one site in the United States, the trial tests whether this common diabetes medication can also help with weight loss when paired with diet changes. Positive findings could support a practical approach to managing both diabetes and excess weight.

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

This Phase 4 trial is recruiting participants in the United States to test medications alongside lifestyle counseling for people who regain weight after bariatric surgery. Maintaining weight loss after surgery can be challenging, and this study is exploring new ways to support long-term success. If effective, these combined treatments could improve the health and well-being of many patients.

Multimodal Glucose Prediction in Type 2 Diabetes

This study is testing a digital health system that gathers glucose and behavior data to better predict blood sugar levels in people with type 2 diabetes. By using mobile apps, patients may get real-time insights to help manage their condition more effectively. The trial is currently recruiting in the United States and could lead to new tools for daily diabetes care.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.